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Biodegradable porous silk microtubes for tissue
vascularization†
V. E. Bosio,*ab J. Brown,b M. J. Rodriguezb and D. L. Kaplanb
Cardiovascular diseases are the leading cause of mortality around the globe, and microvasculature
replacements to help stem these diseases are not available. Additionally, some vascular surgeries
needing small-diameter vascular grafts present different performance requirements. In this work, silk
fibroin scaffolds based on silk/polyethylene oxide blends were developed as microtubes for vasculature
needs and for different tissue regeneration times, mechanical properties and structural designs. Systems
with 13, 14 and 15% silk alone or blended with 1 or 2% of polyethylene oxide (PEO) were used to
generate porous microtubes by gel spinning. Microtubes with inner diameters (IDs) of 150–300 mm and
100 mm wall thicknesses were fabricated. The systems were assessed for porosity, mechanical properties,
enzymatic degradability, and in vitro vascular endothelial cell attachment and metabolic activity. After
14 days, all the tubes supported the proliferation of cells and the cell attachment increased with porosity.
The silk tubes with PEO had similar crystallinity but a higher elastic modulus compared with the systems
without PEO. The silk (13%)/PEO (1%) system showed the highest porosity (20 mm pore diameter on
average), the highest cell attachment and the fastest degradation profile. There was a good correlation
between these parameters with silk concentration and the presence of PEO. The results demonstrate
the ability to generate versatile and tunable tubular biomaterials based on silk–PEO blends with potential
for microvascular grafts.
Introduction
Cardiovascular disease (CVD) is the leading cause of mortality
around the globe and the number of cases continues to grow.
According to the American Heart Association, by 2030, 40.5%
of the US population is projected to have some form of CVD.1
Small-diameter blood vessels are key to CVD due to their
occlusion or damage, thus the replacement of small-diameter
blood vessels (IDo 6 mm) with autografts remains the standard
clinical approach today. However, considerable morbidity is
associated with autologous harvest and scarce availability due
to disease or previous organ harvesting. There is growing research
work intended on replacing the natural vasculature with such
tubing.2–9 In the case of synthetic prostheses, polymers like
polyethylene terephthalate (PET, Dacron) or expanded poly-
tetrafluoroethylene (ePTFE, Gore-Tex) have been studied, but
clinical complications arise, including the regeneration of a
non-functional endothelium and the mismatch between the
mechanical properties of the grafts and native blood vessels
which are key areas of complications.4
To address the above needs, suitable substitutes for small-
diameter grafts are needed. Bioprinting strategies, for example,
have demonstrated their potential use to pattern cells or
fabricate different tissues and organs including blood vessels
or cardiac patches. However, these approaches still have tech-
nical challenges in terms of vascularization, among others.10–14
Mimicking natural vascular architecture and rebuilding micro-
vascular networks remain a challenge.5 To develop functional
and appropriate structures for these small-diameter vessels, key
properties like biocompatibility to promote tissue regeneration
(non-toxic/immunogenic/thrombogenic or susceptible to infections
and a functional endothelium); mechanical properties, similar to
native vessels (compliance, burst pressure, compression resistance
to aneurysms); and processability (low manufacturing costs, readily
available with a large variety of lengths and diameters, sterilizable,
storability) are needed.4,15
Vascular tissue engineering approaches include different
strategies to emulate the natural function of the small-diameter
vessels including cell-based strategies (with prevascularization or
neoangiogenesis (induction in vitro) associated processes) and
scaffold-based strategies (biological scaffolds (acellular matrix) or
synthetic scaffolds (from synthetic or biopolymers)). Even when
decelullarized structures satisfy many of the requirements, one
major limitation of the most animal-derived matrices is that they
lack standardization and reproducibility.16 The use of synthetic
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scaffolds offers advantages like consistency in materials and
fabrication techniques, reproducible standardized design and
high volume production, and the avoidance of the use of animal
sources. However, these systems often suffer from challenges in
cell interactions or thrombolytic responses.
Since different histological structures and mechanical functions
are related to each region of the circulatory system, the fabrication
of scaffolds suitable for these tissue needs requires tunable features
to meet this range in vessel requirements. Therefore, materials with
tunable properties are an advantage. Different degradation rates, for
example, could be relevant in terms of repairs in different zones or
in response to different degrees of damage. The porosity for the
delivery of oxygen and nutrients relates to applications where high
transport rates, but not mechanical strength, are needed versus low
porosity tubes where mechanical integrity, but not transport, is
critical. The rate of tissue ingrowth of grafts can be improved
through optimizing the porosity or the permeability of the
grafts. For synthetic grafts prepared from ePTEF, an intermodal
distance of 30 mm was better than distances of 50 and 100 mm
when tested in humans.17
The ability to construct complex geometries and small
dimensions, the mechanical properties, and the need for bio-
functionalization present additional challenges. Some of these
deficiencies can be addressed with biopolymers due to their
biocompatibility, biodegradability, minimal inflammatory reactions
and excellent mechanical properties. For example, silk-based
materials have been used in tissue regeneration such as for
bone, cartilage, blood vessels, skin and nerves.18–25 The structures
generated based on silk derived from Bombyx mori are easy to store
and sterilize, and, depending on the selected technique, can be
fabricated into scaffolds such as vessels with small dimensions
with tunable geometries.26 Additionally, drug delivery properties of
silk provide a useful option to build structures carrying specific
therapeutic molecules,27,28 including pro-angiogenic growth
factors, to promote the natural development of microvasculature
once the graft is in the body, helping the proliferation of resident
vascular progenitor cells.
The generation of microtubes based on silk has been reported
by our lab previously.29 However, further studies are necessary to
regulate or tune the features of these structures. Thus the focus of
this study was to further refine the relationships between the
processing and degradation of materials, mechanical properties
and porosity of silk tubes in the context of vascular tissue needs.
Compared to dip-coated silk microtubes, the gel-spinning
approach based on silk/polyethylene oxide blends developed
in this study showed tunable degradation behavior, various
mechanical properties, better structural homogeneity and good
cell growth in vitro, implying feasibility for different micro-
vascular tissue requirements.
Experimental
Preparation of aqueous silk solutions
A 5–6% (w/v) silk fibroin (hereafter termed silk) aqueous
solution was obtained from B. mori silkworm cocoons using
previously described procedures.30–35 Briefly, the silkworm
cocoons (supplied by Tajima Shoji Co., Ltd, Yokohama, Japan)
were extracted in 0.02 M sodium carbonate solution by boiling
for 5, 10, 15 or 20 minutes, rinsed with distilled water, dissolved
in 9.3 M lithium bromide, and dialyzed against distilled water
using a cellulose dialysis tubing (molecular weight cutoff,
MWCO, 3500, Fisherbrand by Fisher Scientific, Pittsburgh, PA)
for 48 h. The resulting 5–6% (w/v) silk solution was then
concentrated using a CentriVap Vacuum Concentrator (Labconco,
Kansas City, MO) to produce a 7–15% (w/v) silk aqueous solution.
All silk solutions were stored at 4 1C until the concentration
process.
Winding device and winding of silk-based tubes
A custom silk spinning device (SolidWorks, Concord, MA) with
a spinning mandrel driven by a two-axis stepper motor (Haydon
Switch & Instrument, Waterbury, CT) that drove the mandrel
both axially and rotationally was used to make the microtubes
as described previously.36 The rotational speed was 200 rpm
while the axial slew rate (ASR) was 2 mm s1 over the maximum
(5 cm) stroke length. A Teflon-coated stainless steel rod of
400 mm diameter (McMaster-Carr, Atlanta, GA) was used as the
silk spinning mandrel and was fixed to the motor shaft with a
coupling adapter. Teflon guide blocks, allowing the ends of the
rod to slide freely, stabilized the rod. For silk blend deposition,
a three-axis manipulator was used to precisely position the
syringe needle.36
Tubes were prepared by pushing 10–15% (w/v) silk solution
through a 27 or 29 gauge needle onto a rotating and axially
reciprocating mandrel. After evenly coating with concentrated
silk, the transformation from amorphous liquid to the beta-
sheet crystalline form was induced by treatment with methanol.37
The silk-coated mandrels were placed at 25 1C for 6 hours and
then dried with two lyophilization cycles. After MetOH treatment,
the samples were washed overnight if polyethylene oxide (PEO)
was present or for 2 hours in the absence of PEO. All the
samples were placed in water to remove the silk tubes from
the Teflon-coated stainless steel rods. Prior to any cell-based
experiments, the microtubes were air-dried and sterilized using
ethylene oxide (ETO). The samples were placed in sterilization
pouches and exposed to ETO gas for 10 h, followed by 2 h of
degassing in the sterilizer chamber and an additional 24 h of
degassing in a vacuum oven at room temperature to remove
residual ETO.
Preparation of porous silk/PEO microtubes
Concentrated silk solutions were blended with different volumes
of 5 wt% PEO29 to form ratios of silk/PEO of 100/0, 99/1 and
98/2 (wt%). The silk/PEO blends were gently mixed at 37 1C using
a spatula. Silk and silk/PEO microtubes were prepared using the
same gel-spinning technique as described above, and then frozen
and dried overnight. After drying, the microtubes were treated
with methanol and immersed in distilled water overnight at
room temperature (24 h, 25 1C), thus facilitating the extraction
of the PEO phase and leaving porous microtubes.
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Imaging
The morphology of the silk tubes was observed by scanning
electron microscopy (SEM) (a Zeiss EVO MA10 SEM equipped
with an SE1 detector, Carl Zeiss, Oberkochen, Germany) at
3.0 kV. Fractured sections of the silk-based tubes were obtained
from wet tubes using surgical scissors and dried overnight.
Samples were mounted on a copper plate and sputter-coated
with a 20–30 nm thick Au/Pd layer prior to imaging. The SEM
images, along with image analysis software (ImageJ, National
Institutes of Health, USA), were used to determine wall thickness
and pore size distribution. For pore size distribution, 300 measures
over 3 images were analyzed for each pore size study. HUVECs
present in the microtubes after 3 and 14 days were observed by
optical microscopy (LCS Lite, Leica Microsystems, Mannheim/
Wetzlar, Germany) and stained using Calcein AM/rhodamine
dyes according to company protocols (Invitrogen, Carlsbad, CA)
for live/dead imaging. Image intensities were measured using a
Leica fluorescence microscope (LCS Lite, Leica Microsystems,
Mannheim/Wetzlar, Germany).
Mechanical evaluation
Tensile tests were performed on hydrated silk strips of 2–9 mm
width and 20–30 mm length and fabricated by the same gel-
spinning technique used to make the tubes but with a 10 mm
diameter spinning mandrel. The testing was performed using
an Instron 3366 testing frame (Instron, Norwood, MA) with
5 and 10 N capacity load cells and BioPuls Bath, Submersible
Pneumatic Grips (Instron BioPlus Systems Solutions for Biomedical
Testing, Norwood, MA) under physiological conditions. This char-
acterization was performed for a range of silk-based formulations to
determine the difference in properties as a function of the extraction
boiling time (during the degumming process) and the additive.
Sample tubes (N = 3 each tube type) were hydrated in 0.1 M
phosphate-buffered saline (PBS) for 24 hours before clamping and
submerging in a temperature-controlled BioPuls Bath (37  0.3 1C)
filled with PBS for at least 5min prior to testing. The initial length of
each strip was obtained using a caliper. Small parts of each strip to
be tested were stored and cross sections were prepared for histology.
Hematoxylin and eosin staining were performed to increase
contrast in the cross sections. Images of slides were taken
using an optical microscope (Axiovert S100, Zeiss, Germany)
equipped with a digital imaging video camera (DXC-390, Sony,
Tokyo, Japan). The cross-sectional areas were calculated using
ImageJ from the NIH.38 These cross-sectional areas were used
to calculate stress from the measured force. Samples were
prepared by placing two dots axially for video axial measurements
(Fig. 1). A crosshead displacement rate of 0.01% per min was used,
and video axial strains were measured using video extensometer
software.
Stress and strain were computed from the measured force
and displacement using Bluehill’s Instron software according
to cross-sectional area measurements. The linear elastic modulus
was calculated using a least-squares fitting between 0.02 N load
and 3% strain past that point. The yield strength was determined
by offsetting this least-squares line by 5% strain and marking the
data intercept. Ultimate tensile strength (UTS) was determined as
the highest stress value attained during the test.
Characterization of silk-based tubes
The infrared spectra of the silk and silk/PEO microtubes were
measured using a JASCO FT-IR 6200 spectrometer (JASCO,
Tokyo, Japan). Microtubes were dehydrated in an airflow hood
to minimize the contribution of water peak during FT-IR
analysis, and evaluated with each spectrum acquired over the
range of 4000–400 cm1 for 66 scans with a resolution of
4 cm1. The secondary structure of silk was evaluated by
Fourier self-deconvolution (FSD) of the FTIR spectra covering
the amide I region using Opus 5.0 software.38
Pore size distribution was calculated using SEM images,
along with image analysis software (ImageJ, the National Institutes
of Health, USA). A total of 300 measures were carried out over
3 images for each pore size study, where mean was indicated for
each system as well as standard deviation (SD) values.
Silk-based microtubes were assessed for enzymatic degradation
over time using a protocol described previously.39 Briefly, mass
loss induced by proteolytic degradation was determined by
incubating hydrogels in protease XIV (5.3 units per mg, Sigma-
Aldrich, St. Louis, MO, reconstituted in water by stirring for one
hour). The mass loss was calculated at each time point as weight
loss divided by initial microtube mass during 10 days (1).
Weight loss% = ((W0  Wt)/W0)  100 (1)
Silk-based microtubes (1 cm in length, N = 3 per group and time
point) were incubated in 0.5 mL of 0.1 mg mL1 protease XIV in
water at 37 1C for a period of 21 days. As negative controls, silk-
based microtubes were incubated in water instead of enzymatic
solution.39 Enzyme solution was removed and replaced with
fresh enzyme once every 24 hours for up to 21 days. At each
time point, samples were removed from incubation and washed
with deionized water to remove adsorbed protein. Microtubes
were then air-dried and weighed. For the comparison of the initial
weight, the samples were initially incubated in deionized water for
24 hours at room temperature to remove any soluble material.
Cell culture
Human umbilical vein endothelial cells (HUVECs) (Cambrex,
Walkersville, MD) were used to seed the tubes. Prior to seeding,
Fig. 1 Silk strip (2–9 mm width and 20–30 mm length) fabricated with a
10-mm diameter spinning mandrel. Samples were prepared by placing two
dots axially for video axial measurements. Scale bar = 5 mm. Cross-sectional
SEM images of silk strips (left) and microtubes (right). Scale bar = 100 mm.
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HUVECs were cultured according to previously reported protocols
in optimized growth media (EGM-2) consisting of Endothelial
Basal Medium-2 (Lonza, Walkersville, MD) supplemented with
100 U mL1 penicillin, 1000 U mL1 streptomycin, and 0.2%
fungizone antimycotic (GIBCO, Carlsbad, CA). Cells were cultured
at 37 1C, 5% CO2/95% air, and 95% relative humidity.
Cell culture medium was replenished twice per week, and
cells were passaged four times at approximately 80% confluence
using trypsin-EDTA (0.25% trypsin with 1 mM EDTA-4Na) before
being used to seed the scaffolds.
Silk-based tubes were sterilized using ETO and prior to cell
seeding, microtubes of 5 mm length were presoaked in media
overnight at 37 1C (5% CO2/95% relative humidity) in 48 well
plates. Media were then aspirated from scaffolds the following
day. Microtubes were pre-coated with 10 mg mL1 of collagen
solution and incubated for 30 minutes at 37 1C in order to
improve the attachment outcome (most likely due to the
presence of Arg-Gly-Asp tripeptide (RGD sequences) available
for cell binding)40 and reduce the times for in vitro studies. The
excess collagen was removed by washing with PBS buffer, and
7 mL of cell pre-cultured suspensions were pipetted onto the
scaffolds to reach 2  105 cells. Cells were allowed to attach for
1.5 h at 37 1C (5% CO2/95% RH), and 200 mL of media was then
added to each scaffold (one scaffold/well of 48-well plate) and
replenished every 4 days.41
Metabolic activity
To assess changes and differences in cellular activity, the different
microtubes were assayed every 3 days using Alamar Blue (Invitrogen
Corp, Grand Island, NY). Briefly, a 9 :1 (v/v) dilution of Alamar Blue
to cell culture medium was added directly to the samples and then
incubated for 4 hours. The following incubation fluorescence
readings were taken using a multimode multiplate reader
(SpectraMax M2, Molecular devices, Sunnyvale, CA) at 530 nm
excitation and 590 nm emission using SoftMax Pro software.
Arbitrary units were determined as relative units of fluorescence
intensity from the reduction of resazurin found in Alamar Blue to
red fluorescent resorufin in the presence ofmetabolically active cells.
The same samples were measured at each time point (sample
size per group per time point was n = 3). Graphs were normalized
to the fluorescence reading of the Alamar Blue solution from the
non-seeded scaffolds.
Statistical analysis
All the experiments were independently replicated with a minimum
sample size of N = 3 or N = 300 for pore size measures. Values were
expressed as average (or mean and mode for pore sizes) plus or
minus the standard deviation (SD). Student’s t-test was performed
for paired observations. A value of p o 0.05 was considered
statistically significant.
Results and discussion
Silk-based microtube fabrication
Silk-based tubes were previously generated using a gel-spinning
process with concentrated silk on a stainless steel rod of 400micron
diameter, using methanol to induce b-sheet formation which
provided both stability in aqueous solution as well as improved
mechanical properties.37 This technique provided solid silk
tubes with an ID of about 150–300 micrometers and a wall
thickness of 100 micrometers. To improve the diffusion properties
of silk microtubes, porous tubes were generated by adding 1 and
2 percent of PEO to the concentrated silk. By adding a specific
weight percent of PEO and using different aqueous silk solution
percentages, pores of defined size were obtained. The micro-
tubes were analyzed for pore size distribution and roughness
at the exterior surface as well as at the cross section of the
microtube using SEM.
As shown in Fig. 2, pore size distributions in the silk-based
microtubes were controlled by changing the concentration of
silk as well as by the presence of PEO.29 No difference was
found between 1 and 2 percent of PEO in terms of porosity
(data not shown). Porosity was enhanced with lower silk con-
centrations in silk/PEO blends (Table 1 and Fig. S1 of the ESI†).
The surfactant properties and hydrophilicity of PEO promoted
the porous structures observed in the silk/PEO systems. The
water extraction step after lyophilization of the tubes helped to
leach out PEO to increase the porosity compared with the silk-only
systems.42 Topography analysis using ImageJ was also performed
(see Fig. S2 of the ESI†).
The presence of beta-sheet in all formulations of silk and
silk/PEO microtubes was confirmed using FT-IR (Fig. 3). Each
microtube demonstrated a predominant b-sheet structure (1697,
1623 cm1, amide I; 1514 cm1, amide II), which was induced by
the methanol treatment applied to all microtubes. Methanol
treatment did not enhance the b-sheet structure observed by
FT-IR when PEO was present, and there were no differences in
the amide I and amide II spectral bands between microtubes of
pure silk and those of silk/PEO blends (Fig. 3 and Fig. S3, S4 of
the ESI†), agreeing with previously reported structural data using
silk and PEO films.42
Mechanical properties
The study of strain–stress curves for silk/PEO microtubes in the
initial longitudinal tensile test showed a Young’s modulus as a
function of silk concentration and porosities (Fig. 4).
The uniaxial tensile properties of native human blood
vessels are presented in Table 2. Even with some discrepancies
in the literature among the reported values of various mechanical
properties for the same tissue by different researchers (due to
differences in methods),43 the comparison of elasticity and ultimate
tensile strength among mean values of different material grafts
(natural vessels,44–46 previously developed silk microtubes47 and our
systems) showed an improvement in the mechanical properties
with respect to native blood vessels in terms of ultimate tensile
strength (Table 2). These systems showed average values of UTS of
0.56MPa, and while they are smaller caliber vessels than saphenous
veins (0.5 mm–0.5 cm) or coronary vessels (0.1–10 mm), it is worth
noting that these values are in the order of those of human
saphenous veins, the current gold standard for bypass grafts even
of small diameter vessels (o6 mm),48 and are also higher than our
previously reported silk tubes indicating feasibility for future in vivo
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studies involving tubes manufactured with silk/PEO blends. In
general, these new generation silk/PEO systems showed a smaller
inner diameter compared with previous work, without losing the
mechanical properties and with a non-thrombogenic shape, even
for low silk concentrations.
Table 1 Porosity analysis using ImageJ for silk and silk/PEO blends. Table
comparing all data (SD = standard deviation)
Pore size (mm)
Silk Silk/PEO
13% 14% 15% 13% 14% 15%
Mean 9.61 7.46 4.15 20.01 16.96 7.59
Mode 5.43 4.19 2.19 12.45 13.49 5.03
SD 4.27 4.31 2.61 8.38 6.14 3.23
Fig. 4 Strain–stress curves for samples in initial longitudinal tensile tests.
Average Young’s modulus (E) was calculated between 0 and 5 video axial
strain percentages. Average tensile stress at ultimate tensile strength (UTS)
was calculated from tensile stress vs. video axial strain plots (SD = standard
deviation).
Table 2 Comparison of the mechanical properties of native aorta and
graft material
Material graft Elastic modulus (MPa)
Ultimate tensile
strength (MPa)
Saphenous vein 1.45  0.19 to 23.7  15 0.95  0.11
Coronary vessels 0.81 to 1.72  0.26 0.51 to 1.55  0.87
Silk tubes 2.20  0.90 0.27  0.11
Silk/PEO tubesa 5.11  0.59 0.56  0.11
a Specimens of silk 13% PEO 1.
Fig. 2 Microscopy and SEM images for cross section and length of silk and silk/PEO microtubes. (a) Top to bottom: 13, 14 and 15% silk microtubes;
(b) Top to bottom: Blends of PEO at 1% and silk 13, 14 and 15% microtubes; (c) Top to bottom: One silk microtube (scale bar = 1 cm) and different cross
sections of silk and silk/PEO tubes (scale bar = 1 mm).
Fig. 3 FT-IR spectra for silk and silk/PEO1 blends and quantification of b-sheet
content of silk and silk/PEO1 blends. (#) Not statistically significant (Po 0.05).
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The presence of PEO in the formulations enhanced the
Young’s modulus (Fig. 5). These silk/PEO solution blends reduced
the material’s brittleness and enabled processing and handling
of the final material, providing better conditions for further
processing30,31,49 including gel spinning.
Despite a similar b-sheet content in samples up to 60 minutes
extraction time (ET) and the same methanol treatment,50 the
samples with PEO (10 ET) had different elastic moduli (Fig. 5)
and rheological properties determined by tensile stress and
viscosity (data not shown). The enhancement of E was observed
for different silk concentrations in the silk/PEO systems, when
PEO was present compared with only silk microtubes, or when
the extraction time was increased (data not shown). This feature can
be an advantage to manipulate the material without changing other
properties related to the degumming process.50
Enzymatic degradation
The microtubes were subjected to in vitro proteolytic digestion
using protease XIV based on our previous results.39 Degradation was
observed in all silk samples incubated in the protease solution,
demonstrating a linear degradation rate in terms of weight ratio
(Fig. 6). At each time point, silk microtubes became more brittle,
thereby undergoing degradation. After 14 days a decrease in degra-
dation was observed in all non-PEO systems, and microtubes made
with 15% silk solution showed integrity until the last time point.
The degradation of the silk/PEO microtubes showed a higher
degradation rate than the silk-only tubes. The 13% silk/PEO systems
showed a significant difference from the systems, with the highest
degradation rate. No significant differences were found between the
1 and 2% of PEO for all the systems. Control samples incubated in
water but without enzyme did not exhibit any mass loss.
The microtubes demonstrated varying biodegradation profiles
based on silk concentration and the presence of PEO. This tunable
degradation profile is useful in terms of achieving different tube
properties.
Vascular cell attachment and proliferation
The attachment and proliferation of endothelial cells in vitro
in the tubes were assessed by coating with endothelial cells.
The ability of these cells to grow on silk-based tubes in vitro was
followed by optical and fluorescence microscopy.
As shown in Fig. 7, more cells attached to the silk/PEO
microtubes than the silk-only systems at the same concentrations.
Comparing the silk/PEO systems, better attachment was observed
with higher porosity. This suggests higher potential for the
formation of an endothelial cell lining on the inner surface of
graft lumens for low concentrations of silk/PEO systems.
Fig. 5 Elastic modulus for silk/PEO systems. The samples are referred to
as 10 ET, where ‘‘ET’’ stands for extraction time in minutes. (*) Statistically
significant P o 0.05.
Fig. 6 Enzymatic degradation. Normalized degradation profiles as a
percentage of weight loss (WL) vs. time (t) for silk (different concentrations:
13, 14 and 15%) and blends of silk (13, 14 and 15%) and PEO (1 and 2%).
(*) Statistically significant P o 0.05.
Fig. 7 Optical microcopy images (20) for HUVECs cultured on the micro-
tubes. (a) Top to bottom: Only silk of 13, 14 and 15% (w/v) (b) top to bottom:
PEO 1% and silk of 13, 14 and 15% (w/v). In all images, scale bars = 100 mm;
L = microtube lumen; a = attached cells; b = non-attached cells.
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Despite the optical microscopy attachment observed, the
ALB profiles showed a decrease in cell viability after 4 days for
some structures (silk 13%, silk 13%/PEO and silk 15%), while
the other systems showed similar levels. With poor attachment
to increase the cellular mass on the structures, the transfer
steps during the procedure could affect the final cell amounts
to react with ALB and be responsible of the cell viability
levels.
However, after 14 days, all the systems showed a significant
increase in cell activity detected in spite of the possible losses of
cell mass before the readings, evidence of a stronger adhesion
to the microtubes, suggesting that the graft materials can provide
cell attachment and infiltration necessary for remodeling (Fig. 8).
The proliferation and cell adhesion were monitored by
fluorescence microscopy for calcein AM versus rhodamine-stained
HUVECs in a live/dead study. The images showed that after 14 days,
cells were actively proliferating (Fig. 9).
Conclusions
Microtubes (150–300 mm ID) of silk/PEO blends may offer a
novel tunable system for microvascular grafts. These specific
blends of silk/PEO (13, 14 and 15% of aqueous 10 ET silk
solutions with 1 and 2% of PEO) allowed the fabrication of
homogeneous and reproducible tubular scaffolds with tunable
mechanical properties and controlled degradation behavior using
an aqueous, simple and reproducible method like gel spinning. The
use of 10 ET silk allowed its utility with lower silk concentrations to
enhance results over previous studies, including our reported
systems by dip coating and gel spinning methods.28,36,42,47 These
blends showed different profiles of degradation and porosity for the
microtubes, without losing their structural integrity, crystallinity or
elasticity but achieved patency and smaller external/IDs.
The presence of high viscosity PEO allowed us to work with
lower silk concentrations and avoid complicated procedures
related to manipulating the material during and after the gel
spinning process. As a result, the modulation of tube structures
was possible including avoiding defects during spinning to
decrease the possible zones of platelet adhesion to preserve
non-thrombogenic features.
The porous silk-based microtubes were characterized in
terms of pore size, crystalline structure, mechanical properties,
enzymatic degradation, cell attachment and metabolic activity.
Porous silk microtubes could be produced with good control
over many properties. The presence of PEO increased the
porosity and elasticity in all the systems. Many reports have
suggested the need for improving the porosity and permeability
of the scaffolds to optimize tissue ingrowth for vascular
grafts,7,17,51,52 and these porous silk-based microtubes should
be able to address this need. With 13% silk in the blends,
higher porosity and pores of 20 mm average diameter (in the
size range for better ingrowth tissue rates in humans) were
found accompanied by higher cell attachment and degradability,
the parameters that can improve ingrowth as well. These systems
showed an UTS of 0.56 MPa, on the order of human saphenous
veins, the current gold standard for bypass grafts even of small-
diameter vessels (o6 mm), indicating feasibility for future in vivo
studies involving tubes prepared with silk/PEO blends. In
general, these new-generation silk/PEO systems showed a
smaller inner diameter compared with previous work, without
losing the mechanical properties and with non-thrombogenic
surfaces, even for low silk concentrations, presenting a promising
material for microvasculature replacement. Even when these
materials are compared with human vessels that have larger
inner diameters, they look similar in terms of porosity, while
degradation and remodeling rates will need to be assessed
in vivo. The ability of these silk scaffolds to support vascular cell
adhesion that could remodel the graft material should also be
useful. These microtubes could be included within other kinds of
scaffolds to enable the pre-vascularization process and to build
Fig. 8 Cellular activity. Normalized metabolic activity graphed as fluorescence
intensity in arbitrary units (AU) vs. time for all the systems: (a) silk controls for
different concentrations and (b) silk/PEO (1%) blends. (*, #) Statistically significant
(Po 0.05) and not statistically significant, respectively.
Fig. 9 Live/dead study of HUVECs cultured on half-moon shaped micro-
tubes stained for the study of 14 day cultures. (a) Top to bottom: Silk of 13,
14 and 15% (w/v) (b) top to bottom: PEO 1% and silk of 13, 14 and 15% (w/v).
Calcein AM staining (left, green) shows live cells attached on the micro-
tubes, and rhodamine staining (right, red) shows the microtube matrix
supporting the cells. Scale bars = 100 mm.
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natural connections with existing vasculature by anastomose
processes to avoid graft problems.53
The tunable profile of degradation for silk scaffolds may
offer alternatives to replace microvascular tissues under different
conditions. While these initial results are promising, the relation
between silk scaffold degradation and graft remodeling rates will
need to be assessed in vivo. The addition of therapeutic drugs in
the silk/PEO blends, the inhibition of complement activation,
oxidative stress, and thrombosis pathways may represent additional
variants to pursue with the silk tube systems as potential therapeutic
targets for promoting microvascular health.54
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